Biopharma firm Acelyrin seeks $1.5 billion valuation in US IPO

There are signs that the IPO market is beginning to thaw. Johnson & Johnson Inc is preparing to list its consumer health business Kenvue Inc in New York this Friday, hoping to raise about $3.5 billion. Last week, SoftBank's ARM Ltd filed with regulators confidentially for a U.S. stock market listing, setting stage for largest IPO offering of the year.